917 related articles for article (PubMed ID: 23544853)
1. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.
Akaslan SB; Degertekin CK; Yilmaz G; Cakir N; Arslan M; Toruner FB
Metab Syndr Relat Disord; 2013 Aug; 11(4):243-50. PubMed ID: 23544853
[TBL] [Abstract][Full Text] [Related]
2. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models.
Kim MK; Chae YN; Ahn GJ; Shin CY; Choi SH; Yang EK; Sohn YS; Son MH
Arch Pharm Res; 2017 Feb; 40(2):268-281. PubMed ID: 27885461
[TBL] [Abstract][Full Text] [Related]
4. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
Elshazly SM
Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
[TBL] [Abstract][Full Text] [Related]
5. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
6. Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats.
Maiztegui B; Borelli MI; Madrid VG; Del Zotto H; Raschia MA; Francini F; Massa ML; Flores LE; Rebolledo OR; Gagliardino JJ
Clin Sci (Lond); 2011 Jan; 120(2):73-80. PubMed ID: 20795946
[TBL] [Abstract][Full Text] [Related]
7. Decreased hepatic glucose production in obese rats by dipeptidyl peptidase-IV inhibitor sitagliptin.
Lu YL; Zhou DQ; Zhai HL; Wu H; Guo ZK
Chin Med J (Engl); 2012 May; 125(10):1690-4. PubMed ID: 22800885
[TBL] [Abstract][Full Text] [Related]
8. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Huang Y; Fu JF; Shi HB; Liu LR
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
[TBL] [Abstract][Full Text] [Related]
9. Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.
Apaijai N; Pintana H; Chattipakorn SC; Chattipakorn N
Br J Pharmacol; 2013 Jul; 169(5):1048-57. PubMed ID: 23488656
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
Zhou ST; Cui W; Kong L; Yang X
Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
[TBL] [Abstract][Full Text] [Related]
12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
13. Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease.
Sakr HF; Abbas AM; Haidara MA
J Basic Clin Physiol Pharmacol; 2018 Jan; 29(1):61-71. PubMed ID: 29161233
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
[TBL] [Abstract][Full Text] [Related]
15. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
16. Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.
Cui WX; Yang J; Chen XQ; Mao Q; Wei XL; Wen XD; Wang Q
Am J Chin Med; 2013; 41(3):487-502. PubMed ID: 23711137
[TBL] [Abstract][Full Text] [Related]
17. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
[TBL] [Abstract][Full Text] [Related]
18. Levocetirizine ameliorates high fructose diet-induced insulin resistance, vascular dysfunction and hepatic steatosis in rats.
Shawky NM; Shehatou GS; Abdel Rahim M; Suddek GM; Gameil NM
Eur J Pharmacol; 2014 Oct; 740():353-63. PubMed ID: 25064340
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet.
Souza-Mello V; Gregório BM; Cardoso-de-Lemos FS; de Carvalho L; Aguila MB; Mandarim-de-Lacerda CA
Clin Sci (Lond); 2010 Jun; 119(6):239-50. PubMed ID: 20415664
[TBL] [Abstract][Full Text] [Related]
20. DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats.
Pintana H; Apaijai N; Chattipakorn N; Chattipakorn SC
J Endocrinol; 2013 Jul; 218(1):1-11. PubMed ID: 23591914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
